Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.
about
Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Is Age ≥ 70 Years an Important ...... nalyses of Therapeutic Trials.
@en
type
label
Is Age ≥ 70 Years an Important ...... nalyses of Therapeutic Trials.
@en
prefLabel
Is Age ≥ 70 Years an Important ...... nalyses of Therapeutic Trials.
@en
P2093
P2860
P1476
Is Age ≥ 70 Years an Important ...... nalyses of Therapeutic Trials.
@en
P2093
Aminah Jatoi
Edward T Creagan
Gary A Croghan
Jacob B Allred
Svetomir N Markovic
Thomas Amatruda
Vera J Suman
P2860
P304
P356
10.1016/J.JGO.2012.04.002
P577
2012-05-07T00:00:00Z